True Rx Health Strategists Revenue and Competitors

Washington, IN USA

Location

N/A

Total Funding

Insurance

Industry

Estimated Revenue & Valuation

  • True Rx Health Strategists's estimated annual revenue is currently $45.5M per year.(i)
  • True Rx Health Strategists's estimated revenue per employee is $242,000

Employee Data

  • True Rx Health Strategists has 188 Employees.(i)
  • True Rx Health Strategists grew their employee count by 55% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5550.8M180221%N/AN/A
#2
$3.7M24-23%N/AN/A
#3
$3.7M244%N/AN/A
#4
$6.9M39-9%N/AN/A
#5
$5.6M323%N/AN/A
#6
$6.9M39-2%N/AN/A
#7
$18.5M84-1%N/AN/A
#8
$1.7M13-13%N/AN/A
#9
$13.9M708%N/AN/A
#10
$0.1M1-92%N/AN/A
Add Company

The pharmacists and strategists at True Rx champion health, integrity, and innovation nationwide by providing affordable pharmacy benefit solutions to employers.  True Rx is transcending the industry with flexibility, price, and a high-touch approach to optimize employee health.

keywords:N/A

N/A

Total Funding

188

Number of Employees

$45.5M

Revenue (est)

55%

Employee Growth %

N/A

Valuation

N/A

Accelerator

True Rx Health Strategists's People

NameTitleEmail/Phone
1
System AdministratorReveal Email/Phone
2
CEOReveal Email/Phone
3
Director Buiness ReportingReveal Email/Phone
4
Account ManagerReveal Email/Phone
5
Clinical PharmacistReveal Email/Phone
6
Account ManagerReveal Email/Phone
7
VP Client ServicesReveal Email/Phone
8
Project Management Office (PMO), ManagerReveal Email/Phone
9
Cyber Security AdministratorReveal Email/Phone
10
Client Relations ManagerReveal Email/Phone

True Rx Health Strategists News

2022-04-17 - Democrats and the 2022 Midterms: ‘It’s Going to Be a Terrible Cycle’

one Democratic strategist quipped at the outset of a recent phone call. ... insists represents the Republican Party's true policy agenda.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15M1884%N/A
#2
$15M18810%N/A
#3
$15M1892%N/A
#4
$48.6M1898%N/A
#5
$35M1895%N/A